FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and ObesityXiaoxin X. Wang, Moshe Levi, Suman Ranjit et al.|Journal of the American Society of Nephrology|2017Cited by 222
A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USABiyao Zou, Mindie H. Nguyen, Edward Sheen et al.|Digestive Diseases and Sciences|2019Cited by 35